elecoglipron

Peptides

Elecoglipron: The First Credible Oral GLP-1 Pill Clears a Phase 2 Hurdle

AstraZeneca's once-daily small molecule posts placebo-controlled weight-loss data in The Lancet — and hints at a future where the obesity revolution doesn't require a needle.

Peptides

The Oral GLP-1 Era Begins: Two Pills Move Toward the Mainstream

Two new trials in The Lancet put the first credible oral, non-peptide GLP-1 drugs on the runway — a shift that could change who actually gets access to this class.